Completing data — refresh the page later to see the latest
42182-27-4N#Cc1ccnc(N)c1GEEAYLFEIFJFGP-UHFFFAOYSA-N42182-27-4DTXSID40426745Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H301+H311+H331 (81.6%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Description2-Amino-4-cyanopyridine is a pharmaceutical intermediate compound with two functional groups—an amino group and a cyano group—in its molecular structure, which are the primary factors contributing to its reactivity. It can also be used as a cyanide source for the preparation of organic light-emitting materials.
Uses2-Amino-4-cyanopyridine is used in the treatment of central nervous system (CNS) disorders and as a mGluR2 antagonist.
Uses2-Amino-4-cyanopyridine is a pyridine derivative as mGluR2 antagonists; used in the treatment of CNS disorders.